TABLE 1.
General demographic parameters and clinical manifestations.
| PD group | SP group | |
| Demographics | ||
| No. of participants | 39 | 39 |
| Age (years, mean ± SD) | 63.95 ± 6.92 | 64.82 ± 6.86 |
| Male | 21 | 18 |
| BMI (kg/m2, IQR) | 23.15 (20.67–25.39) | 24.2 (20.2–26.02) |
| Clinical data | ||
| Age at onset (years, mean ± SD) | 60.49 ± 6.54 | – |
| Duration (years) | ||
| ≥3 years | 21 | – |
| >3 ≤ 5 years | 11 | – |
| >5 ≤ 10 years | 6 | – |
| >10 years | 1 | – |
| H&Y stage | ||
| 1 | 12 | – |
| 1.5 | 8 | – |
| 2 | 6 | – |
| 2.5 | 6 | – |
| 3 | 3 | – |
| 3.5 | 1 | – |
| 4 | 3 | – |
| UPDRS-III score (mean ± SD) | 34.92 ± 20.25 | – |